S100A6 promotes proliferation of intrahepatic cholangiocarcinoma cells via the activation of the p38/MAPK pathway

被引：13
|
作者：
Zheng, Susu [1 ,2 ]
Shen, Hujia [1 ,2 ]
Jia, Qingan [1 ,2 ]
Jing, Chuyu [1 ,2 ]
Lin, Jiajia [1 ,2 ]
Zhang, Meixia [1 ,2 ]
Zhang, Xiaolei [3 ]
Zhang, Boheng [1 ,2 ]
Liu, Yinkun [1 ,2 ]
机构：
[1] Fudan Univ, Liver Canc Inst, Dept Hepat Oncol, Shanghai 20032, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Shanghai 20032, Peoples R China
[3] Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 20032, Peoples R China
来源：
FUTURE ONCOLOGY | 2017年 / 13卷 / 23期
基金：
中国国家自然科学基金;
关键词：
intrahepatic cholangiocarcinoma; prognosis; proliferation; S100A6; HUMAN HEPATOCELLULAR-CARCINOMA; GASTRIC-CANCER; THERAPEUTIC TARGET; MAPK PATHWAYS; EXPRESSION; PROTEIN; KINASE; CALCYCLIN; MIGRATION; GROWTH;
D O I：
10.2217/fon-2017-0199
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Aim: We explored the expression of S100A6 and its role in intrahepatic cholangiocarcinoma (ICC). Methods: The expression of S100A6 in ICC samples was detected by immunohistochemistry. In vitro experiments, we silenced and overexpressed S100A6 to investigate its role in cell functions. Results: The expression of S100A6 was markedly increased in ICC tissues and cell lines. S100A6 overexpression was an independent risk factor for patients' survival. Silencing S100A6 resulted in a suppression of proliferation and p38/MAPK activity, while overexpressing S100A6 caused a promotion of proliferation and p38/MAPK. Discussion: S100A6 participated in the proliferation of ICC cells and correlated with a more aggressive behavior of ICC. Conclusion: S100A6 may serve as a novel prognostic marker and a potential therapeutic target for ICC patients.
引用
收藏
页码：2053 / 2063
页数：11
相关论文
共 50 条
  • [1] S100A11 promotes cell proliferation via P38/MAPK signaling pathway in intrahepatic cholangiocarcinoma
    Zhang, Mei-xia
    Gan, Wei
    Jing, Chu-yu
    Zheng, Su-su
    Yi, Yong
    Zhang, Juan
    Xu, Xin
    Lin, Jia-jia
    Zhang, Bo-heng
    Qiu, Shuang-jian
    MOLECULAR CARCINOGENESIS, 2019, 58 (01) : 19 - 30
  • [2] S100A6 promotes cell proliferation in human nasopharyngeal carcinoma via the p38/MAPK signaling pathway
    Li, Anchuan
    Shi, Dingbo
    Xu, Benhua
    Wang, Jingshu
    Tang, Yan-Lai
    Xiao, WeiWei
    Shen, Guanzhu
    Deng, Wuguo
    Zhao, Chong
    MOLECULAR CARCINOGENESIS, 2017, 56 (03) : 972 - 984
  • [3] Ginkgetin promotes proliferation and migration of Schwann cells via PIGF/p38 MAPK signaling pathway
    Zhang, Yong
    Niu, Yanfen
    Weng, Qiuyan
    TISSUE & CELL, 2022, 79
  • [4] Ginkgetin promotes proliferation and migration of Schwann cells via PIGF/ p38 MAPK signaling pathway
    Zhang, Yong
    Niu, Yanfen
    Weng, Qiuyan
    TISSUE & CELL, 2022, 79
  • [5] S100P regulates trophoblast-like cell proliferation via P38 MAPK pathway
    Zhu, Hai-Yan
    Wang, Jun-Xia
    Tong, Xiao-Mei
    Xue, Ya-Mei
    Zhang, Song-Ying
    GYNECOLOGICAL ENDOCRINOLOGY, 2015, 31 (10) : 796 - 800
  • [6] SSH1 promotes progression of intrahepatic cholangiocarcinoma via p38 MAPK-CXCL8 axis
    Chen, Fanghua
    Aye, Ling
    Yu, Lei
    Liu, Longzi
    Liu, Yuming
    Lin, Youpei
    Gao, Dongmei
    Gao, Qiang
    Zhang, Shu
    CARCINOGENESIS, 2023, 44 (03) : 232 - 241
  • [7] Ubiquitin D promotes the progression of rheumatoid arthritis via activation of the p38 MAPK pathway
    Chen, Hong
    Tao, Liju
    Liang, Juhua
    Pan, Chunfeng
    Wei, Hua
    MOLECULAR MEDICINE REPORTS, 2023, 27 (02)
  • [8] Irisin promotes cementoblast differentiation via p38 MAPK pathway
    Zhu, Jiaqi
    Wang, Yunlong
    Cao, Zhengguo
    Du, Mingyuan
    Hao, Yunru
    Pan, Jiawen
    He, Hong
    ORAL DISEASES, 2020, 26 (05) : 974 - 982
  • [9] Dehydrocorydaline promotes myogenic differentiation via p38 MAPK activation
    Yoo, Miran
    Lee, Sang-Jin
    Kim, Yong Kee
    Seo, Dong-Wan
    Baek, Nam-In
    Ryu, Jae-Ha
    Kang, Jong-Sun
    Bae, Gyu-Un
    MOLECULAR MEDICINE REPORTS, 2016, 14 (04) : 3029 - 3036
  • [10] S100A16 suppresses the proliferation, migration and invasion of colorectal cancer cells in part via the JNK/p38 MAPK pathway
    Ou, Shiyu
    Liao, Yan
    Shi, Jie
    Tang, Jing
    Ye, Yanqing
    Wu, Fengfei
    Wang, Weidong
    Fei, Jieying
    Xie, Fang
    Bai, Lan
    MOLECULAR MEDICINE REPORTS, 2021, 23 (02)
12345